AU5079401A - Kcnb: a novel potassium channel protein - Google Patents
Kcnb: a novel potassium channel proteinInfo
- Publication number
- AU5079401A AU5079401A AU5079401A AU5079401A AU5079401A AU 5079401 A AU5079401 A AU 5079401A AU 5079401 A AU5079401 A AU 5079401A AU 5079401 A AU5079401 A AU 5079401A AU 5079401 A AU5079401 A AU 5079401A
- Authority
- AU
- Australia
- Prior art keywords
- kcnb
- potassium channel
- channel protein
- novel potassium
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000004257 Potassium Channel Human genes 0.000 title abstract 2
- 108020001213 potassium channel Proteins 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 108091005461 Nucleic proteins Chemical group 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000011895 specific detection Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18691500P | 2000-03-03 | 2000-03-03 | |
| PCT/US2001/006801 WO2001066741A2 (en) | 2000-03-03 | 2001-03-02 | Kcnb: a novel potassium channel protein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5079401A true AU5079401A (en) | 2001-09-17 |
Family
ID=22686808
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU5079401A Pending AU5079401A (en) | 2000-03-03 | 2001-03-02 | Kcnb: a novel potassium channel protein |
| AU2001250794A Ceased AU2001250794B2 (en) | 2000-03-03 | 2001-03-02 | Kcnb: a novel potassium channel protein |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001250794A Ceased AU2001250794B2 (en) | 2000-03-03 | 2001-03-02 | Kcnb: a novel potassium channel protein |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7462465B2 (https=) |
| EP (1) | EP1266003B1 (https=) |
| JP (2) | JP2004500825A (https=) |
| CN (1) | CN1426468A (https=) |
| AT (1) | ATE538201T1 (https=) |
| AU (2) | AU5079401A (https=) |
| CA (1) | CA2401906C (https=) |
| ES (1) | ES2378417T3 (https=) |
| IL (2) | IL151564A0 (https=) |
| NZ (1) | NZ521205A (https=) |
| WO (1) | WO2001066741A2 (https=) |
| ZA (1) | ZA200206999B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060246432A1 (en) * | 2001-12-31 | 2006-11-02 | Shuster Samuel J | Methods and materials for modulating task-3 |
| WO2005052586A2 (en) * | 2003-11-27 | 2005-06-09 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 3 (kcnk3) |
| WO2005075510A1 (en) * | 2004-02-04 | 2005-08-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 9 (kcnk9) |
| US12416024B2 (en) | 2018-03-29 | 2025-09-16 | Transworld Technologies Inc. | Biologically enhanced oil recovery methods |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2744730B1 (fr) * | 1996-02-08 | 1998-04-17 | Centre Nat Rech Scient | Nouvelle famille de canaux potassium de mammifere, leur clonage et leur utilisation notamment pour le criblage de drogues |
| EP1051485A1 (en) | 1998-01-27 | 2000-11-15 | Smithkline Beecham Plc | Trek-1 like two pore potassium channel |
| WO2000000610A2 (en) | 1998-06-26 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Human signal peptide-containing proteins |
| WO2000027871A2 (en) | 1998-11-09 | 2000-05-18 | Centre National De La Recherche Scientifique - Cnrs | New family of mammalian potassium channels, their cloning and their use, especially for the screening of drugs |
| EP1165777A2 (en) * | 1999-03-05 | 2002-01-02 | Smithkline Beecham Plc | Genes encoding human potassium channel proteins |
| US20020137202A1 (en) * | 1999-12-21 | 2002-09-26 | Catherine Burgess | Novel proteins and nucleic acids encoding same |
| AU3087801A (en) | 2000-02-04 | 2001-08-14 | Molecular Dynamics Inc | Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells |
| AU2001249906A1 (en) | 2000-04-06 | 2001-10-23 | Incyte Genomics, Inc. | Human transporters and ion channels |
| WO2002026983A2 (en) | 2000-09-25 | 2002-04-04 | Millennium Pharmaceuticals, Inc. | 56115, a novel human twik potassium channel and uses therefor |
-
2001
- 2001-03-02 NZ NZ521205A patent/NZ521205A/en unknown
- 2001-03-02 IL IL15156401A patent/IL151564A0/xx unknown
- 2001-03-02 JP JP2001565895A patent/JP2004500825A/ja active Pending
- 2001-03-02 US US09/798,584 patent/US7462465B2/en not_active Expired - Fee Related
- 2001-03-02 ES ES01924111T patent/ES2378417T3/es not_active Expired - Lifetime
- 2001-03-02 AT AT01924111T patent/ATE538201T1/de active
- 2001-03-02 AU AU5079401A patent/AU5079401A/xx active Pending
- 2001-03-02 WO PCT/US2001/006801 patent/WO2001066741A2/en not_active Ceased
- 2001-03-02 CA CA2401906A patent/CA2401906C/en not_active Expired - Lifetime
- 2001-03-02 AU AU2001250794A patent/AU2001250794B2/en not_active Ceased
- 2001-03-02 EP EP01924111A patent/EP1266003B1/en not_active Expired - Lifetime
- 2001-03-02 CN CN01808748A patent/CN1426468A/zh active Pending
-
2002
- 2002-08-30 ZA ZA200206999A patent/ZA200206999B/en unknown
- 2002-09-02 IL IL151564A patent/IL151564A/en not_active IP Right Cessation
-
2008
- 2008-01-03 US US11/968,795 patent/US20080234470A1/en not_active Abandoned
-
2011
- 2011-01-13 JP JP2011005342A patent/JP2011115169A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20080234470A1 (en) | 2008-09-25 |
| NZ521205A (en) | 2005-09-30 |
| IL151564A (en) | 2008-11-03 |
| JP2011115169A (ja) | 2011-06-16 |
| US7462465B2 (en) | 2008-12-09 |
| WO2001066741A2 (en) | 2001-09-13 |
| CA2401906C (en) | 2011-07-19 |
| EP1266003B1 (en) | 2011-12-21 |
| US20020102676A1 (en) | 2002-08-01 |
| WO2001066741A3 (en) | 2002-04-04 |
| CN1426468A (zh) | 2003-06-25 |
| IL151564A0 (en) | 2003-04-10 |
| CA2401906A1 (en) | 2001-09-13 |
| ATE538201T1 (de) | 2012-01-15 |
| WO2001066741A9 (en) | 2003-03-06 |
| EP1266003A2 (en) | 2002-12-18 |
| ES2378417T3 (es) | 2012-04-12 |
| JP2004500825A (ja) | 2004-01-15 |
| ZA200206999B (en) | 2004-05-31 |
| AU2001250794B2 (en) | 2006-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2085502A (en) | Diagnosis and treatment of disease | |
| MXPA05008143A (es) | Eventos de alfalfa tolerantes a glifosato y metodos para su deteccion. | |
| ATE319855T1 (de) | Abspaltbare, nicht-flüchtige moleküle zur massenmarkierung | |
| DE60023936D1 (de) | Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen | |
| AU4981101A (en) | Subtilisin variants | |
| DE60330842D1 (de) | Für den nachweis von nukleinsäuren kompetente biologische rohderivate | |
| BRPI0001536B8 (https=) | ||
| WO2002006458A3 (en) | Protease specific cleavable luciferases and methods of use thereof | |
| IL179441A0 (en) | Hif prolyl hydroxylase activity assay | |
| AU2001238212A1 (en) | Modified fluorescent proteins | |
| IL149791A0 (en) | Oligonucleotides and assemblies thereof useful in the detection of the presence or absence of target nucleic acid sequences in a sample | |
| TR200200667T2 (tr) | Leu-hirudinin E.coli ile kültür ortamında ayrışarak üretilmesinin sinyal sekansları. | |
| ATE389881T1 (de) | Detektion von kleinen molekülen mit piezo- elektrischem sensor | |
| AU5079401A (en) | Kcnb: a novel potassium channel protein | |
| Li et al. | Possible release of an ArgGlyArgProGln pentapeptide with innate immunity properties from acidic proline-rich proteins by proteolytic activity in commensal Streptococcus and Actinomyces species | |
| DE69734586D1 (de) | Retinoid-metabolisierendes protein | |
| WO2004070012A3 (en) | Cell-killing molecules and methods of use thereof | |
| BR0014518A (pt) | Método e ácidos nucléicos para a detecção de microorganismos pertinentes à fermentação | |
| MXPA03004539A (es) | Luciferasas aisladas y uso de las mismas. | |
| WO2001079272A3 (en) | Sitosterolemia susceptibility gene (ssg): compositions and methods of use | |
| DE69838615D1 (de) | ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN | |
| WO2001031009A3 (en) | Chandra: a th1-specific gene | |
| EP1512740A4 (en) | CEREULIDE SYNTHASE PRODUCED BY BACILLUS CEREUS, GENE ENCODING SAME, AND METHOD OF DETECTING CEREULIDE | |
| BR0108767A (pt) | Adenilciclase recombinante, polinucleotìdeo, vetor, processos para a detecção de atividade proteolìtica de uma molécula e da resistência a um inibidor, de uma molécula com atividade proteolìtica e de identificação de moléculas com atividade proteolìtica sìtio-especìfica, kit de diagnóstico, utilização de uma adenilciclase, e, cepa bacteriana | |
| WO2005057486A3 (en) | Protein engineering with analogous contact environments |